SCOPUS 정보 검색 플랫폼

Volumn 85, Issue 1, 2001, Pages 47-51

Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia

(8) Joukhadar, C a Klein, N a Prinz, M a Schrolnberger, C a Vukovich, T a Wolzt, M a Schmetterer, L a Dorner, G T a

a MEDICAL UNIVERSITY OF VIENNA (Austria)

Author keywords

C reactive protein; Hemostatic factors; HMG CoA reductase inhibitor

Indexed keywords

ATORVASTATIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; FIBRINOGEN; PRAVASTATIN; PROTHROMBIN; SIMVASTATIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOGENESIS;

EID: 0035173483 PISSN: 03406245 EISSN: None Source Type: Journal
DOI: 10.1055/s-0037-1612902 Document Type: Article

Times cited : (116)

References (36)

1
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
- (1995) N Engl J Med , vol.333 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, C.G.⁴ Lorimer, A.R.⁵ MacFarlane, P.W.⁶ McKillop, J.H.⁷ Packard, C.J.⁸

2
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- (1994) Lancet , vol.344 , pp. 1383-1389

3
- 0028845911
- Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
- (1995) Circulation , vol.92 , pp. 2419-2425
- Byington, R.P.¹ Jukema, J.W.² Salonen, J.T.³ Pitt, B.⁴ Bruschke, A.V.⁵ Hoen, H.⁶ Furberg, C.D.⁷ Mancini, G.B.⁸

4
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³ Rouleau, J.L.⁴ Rutherford, J.D.⁵ Cole, T.G.⁶ Brown, L.⁷ Warnica, J.W.⁸ Arnold, J.M.⁹ Wun, C.C.¹⁰ Davis, B.R.¹¹ Braunwald, E.¹²

5
- 0032554676
- Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
- (1998) Circulation , vol.97 , pp. 1440-1445

6
- 0032572043
- Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
- (1998) JAMA , vol.279 , pp. 1643-1650
- Rosenson, R.S.¹ Tangney, C.C.²

7
- 0027322448
- Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease
- (1993) Circulation , vol.87 , pp. 1781-1791
- Brown, B.G.¹ Zhao, X.Q.² Sacco, D.E.³ Albers, J.J.⁴

8
- 0028866519
- Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction
- (1995) Circulation , vol.92 , pp. 3172-3177
- Lacoste, L.¹ Lam, J.Y.² Hung, J.³ Letchacovski, G.⁴ Solymoss, C.B.⁵ Waters, D.⁶

9
- 0028939363
- The effect of cholesterol lowering and antioxidant therapy on endothelium dependent coronary vasomotion
- (1995) N Engl J Med , vol.332 , pp. 488-493
- Anderson, T.J.¹ Meredith, I.T.² Yeung, A.C.³ Frei, B.⁴ Selwyn, A.P.⁵ Ganz, P.⁶

10
- 0027191073
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
- (1993) Lancet , vol.341 , pp. 1496-1500
- Leung, W.H.¹ Lau, C.P.² Wong, C.K.³

11
- 0028283817
- Reduction in plasma cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
- (1994) Circulation , vol.89 , pp. 2519-2524
- Egashira, K.¹ Hirooka, Y.² Kai, H.³ Sugimachi, M.⁴ Suzuki, S.⁵ Inou, T.⁶ Takeshita, A.⁷

12
- 0032956961
- Natural statins and stroke risk
- (1999) Circulation , vol.99 , pp. 185-188
- Furberg, C.D.¹

13
- 0030953045
- Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences
- (1997) Clin Pharmacokinet , vol.32 , pp. 403-425
- Lennernas, H.¹ Fager, G.²

14
- 33745551242
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
- (1957) Acta Haematol , vol.17 , pp. 237-246
- Clauss, A.¹

15
- 0022613476
- Sample size calculations for clinical pharmacology studies
- (1986) Clinical Pharmacology and Therapeutics , vol.39 , pp. 489-490
- Stolley, P.D.¹ Strom, B.L.²

16
- 0033117022
- Pravastatin therapy in hyperlipidemia: Effects on thrombus formation and the systemic hemostatic profile
- (1999) J Am Coll Cardiol , vol.33 , pp. 1294-1304
- Dangas, G.¹ Badimon, J.J.² Smith, D.A.³ Unger, A.H.⁴ Levine, D.⁵ Shao, J.H.⁶ Meraj, P.⁷ Fier, C.⁸ Fallon, J.T.⁹ Ambrose, J.A.¹⁰

17
- 0030837459
- Platelet-dependent thrombin generation in patients with hyperlipidemia
- (1997) J Am Coll Cardiol , vol.30 , pp. 91-96
- Aoki, I.¹ Aoki, N.² Kawano, K.³ Shimoyama, K.⁴ Maki, A.⁵ Homori, M.⁶ Yanagisawa, A.⁷ Yamamoto, M.⁸ Kawai, Y.⁹ Ishikawa, K.¹⁰

18
- 0032499382
- Statins and fibrinogen
- (1998) Lancet , vol.351 , pp. 1430-1431
- Black, D.M.¹

19
- 0031025656
- Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis
- (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 265-272
- Colli, S.¹ Eligini, S.² Lalli, M.³ Camera, M.⁴ Paoletti, R.⁵ Tremoli, E.⁶

20
- 0032499382
- Statins and fibrinogen
- (1998) Lancet , vol.351 , pp. 1430-1431
- Haverkage, F.¹ Koopman, J.² De Maat, M.P.³

21
- 85045781423
- Statins and C-reactive protein
- (1999) Lancet , vol.353 , pp. 1274
- Kluft, C.¹ De Maat, M.P.² Gevers Leuven, J.A.³ Pooter Van Loon, B.J.⁴ Mohrschladt, M.F.⁵

22
- 0031020585
- Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group
- (1997) Eur Heart J , vol.18 , pp. 235-241
- Mitropoulos, K.A.¹ Armitage, J.M.² Collins, R.³ Meade, T.W.⁴ Reeves, B.E.⁵ Wallendszus, K.R.⁶ Wilson, S.S.⁷ Lawson, A.⁸ Peto, R.⁹

23
- 0033537351
- Effect of statins on C-reactive protein in patients with coronary artery disease
- (1999) Lancet , vol.353 , pp. 118-119
- Stranberg, T.E.¹ Vanhanen, H.² Tikkanen, M.J.³

24
- 0032554333
- Effect of atorvastatin on plasma fibrinogen
- (1998) Lancet , vol.351 , pp. 569-570
- Wierzbicki, A.S.¹ Lumb, P.J.² Semra, Y.K.³ Crook, M.A.⁴

25
- 0033117206
- Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia
- (1999) J Am Coll Cardiol , vol.33 , pp. 1286-1293
- Szczeklik, A.¹ Musial, J.² Undas, A.³ Gajewski, P.⁴ Gora, P.⁵ Swadzba, J.⁶ Jankowski, M.⁷

26
- 0027099695
- Hypercoagulable state in patients with hypercholesterolemia: Effects of pravastatin
- (1992) Clin Ther , vol.14 , pp. 829-834
- Wada, H.¹ Mori, Y.² Kaneko, T.³ Wakita, Y.⁴ Minamikawa, K.⁵ Ohiwa, M.⁶ Tamaki, S.⁷ Yokoyama, N.⁸ Kobayashi, T.⁹ Deguchi, K.¹⁰ Shirakawa, S.¹¹ Suzuki, K.¹²

27
- 0027764621
- Fibrinogen as a cardiovascular risk factor - Interrelationship with infections and inflammation
- (1993) Eur Heart J , vol.14 , Issue.SUPPL. K , pp. 82-87
- Ernst, E.¹

28
- 0022485106
- Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
- (1986) Lancet , vol.2 , pp. 533-537
- Meade, T.W.¹ Mellows, S.² Brozovic, M.³ Miller, G.J.⁴ Chakrabarti, R.R.⁵ North, W.R.⁶ Haines, A.P.⁷ Stirling, Y.⁸ Imeson, J.D.⁹ Thompson, S.G.¹⁰

29
- 0027441963
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
- (1993) Lancet , vol.342 , pp. 1076-1079
- Meade, T.W.¹ Ruddock, V.² Stirling, Y.³ Chakrabarti, R.⁴ Miller, G.J.⁵

30
- 0021210911
- Fibrinogen as a risk factor for stroke and myocardial infarction
- (1984) N Engl J Med , vol.311 , pp. 501-505
- Wilhelmsen, L.¹ Svardsudd, K.² Korsan-Bengtsen, K.³ Larsson, B.⁴ Welin, L.⁵ Tibblin, G.⁶

31
- 0028909230
- Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
- (1995) N Engl J Med , vol.332 , pp. 635-641
- Thompson, S.G.¹ Kienast, J.² Pyke, S.D.M.³ Haverkate, F.⁴ Van De Loo, J.C.W.⁵

32
- 0032032592
- Comparative Dose Efficacy Study of Atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (the CURVES Study)
- (1998) Am J Cardiol , vol.81 , pp. 582-587
- Jones, P.¹ Kafonek, S.² Laurona, I.³ Hunninghake, D.⁴

33
- 0032732475
- Dosing of atorvastatin and increases in fibrinogen level
- (1999) Atherosclerosis , vol.147 , pp. 421-422
- Sinzinger, H.¹ Rodrigues, M.² Furberg, C.D.³

34
- 0029142708
- Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease
- (1995) Atherosclerosis , vol.16 , pp. 191-198
- Blann, A.D.¹ Maxwell, S.R.J.² Burrows, G.³ Miller, J.P.⁴

35
- 0030745271
- Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
- (1997) Atherosclerosis , vol.32 , pp. 151-156
- Blann, A.D.¹ Miller, J.P.² McCollum, C.N.³

36
- 0031978716
- Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
- (1998) J Hypertension , vol.16 , pp. 537-541
- Agewall, S.¹ Wikstrand, J.² Fagerberg, B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.